-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Relay Therapeutics, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2019 to 2024.
- Relay Therapeutics, Inc. Operating Income (Loss) for the quarter ending March 31, 2024 was -$90.4 M, a 10.7% increase year-over-year.
- Relay Therapeutics, Inc. Operating Income (Loss) for the twelve months ending March 31, 2024 was -$362 M, a 7.24% decline year-over-year.
- Relay Therapeutics, Inc. annual Operating Income (Loss) for 2023 was -$373 M, a 24.6% decline from 2022.
- Relay Therapeutics, Inc. annual Operating Income (Loss) for 2022 was -$299 M, a 17.9% increase from 2021.
- Relay Therapeutics, Inc. annual Operating Income (Loss) for 2021 was -$365 M, a 554% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)